Li Y-R#, Zhu Y, Li Z, Shen X, Halladay T, Tse C, Tian Y, Huang J, Zhao AS, Ma NY, Zhang C, Nathanson DA, Prins RM, and Yang L#. (#Co-corresponding authors). Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety. Mol Ther. 2025 September 12:S1525-0016(25)00754-3. doi: 10.1016/j.ymthe.2025.09.026. Online ahead of print. [Molecular Therapy PDF][Molecular Therapy Commentary PDF]
